Wells Fargo & Co. upgrades AmSurg shares — 5 notes

Wells Fargo & Co. boosted Nashville, Tenn.-base AmSurg’s rating from a “market perform” to an “outperform,” according to Daily Quint.

Advertisement

Here are five notes:

1. On Jan. 3, 2017, AmSurg shares opened the day trading at $66.82.

2. The company has a 52-week low is $57.75.

3. The 52-week high is $87.29.

4. AmSurg’s 50-day moving average price is $64.56 and its 200-day moving average price is $71.69.

5. The company’s market cap is $3.59 billion.

More articles on surgery centers:
Envision Healthcare Corp. expands in Arizona through Oro Valley Anesthesia acquisition: 4 highlights
Aurora Health Care to unveil ASC, hospital plans to community: 4 key points
25 statistics on EBITDA margins for ASCs

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.